Cargando…
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
Cancer treatment is undergoing a significant revolution from “one-size-fits-all” cytotoxic therapies to tailored approaches that precisely target molecular alterations. Precision strategies for drug development and patient stratification, based on the molecular features of tumors, are the next logic...
Autores principales: | Coyle, Krysta Mila, Boudreau, Jeanette E., Marcato, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480027/ https://www.ncbi.nlm.nih.gov/pubmed/28685150 http://dx.doi.org/10.1155/2017/9620870 |
Ejemplares similares
-
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
por: Coyle, Krysta Mila, et al.
Publicado: (2017) -
DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid
por: Coyle, Krysta Mila, et al.
Publicado: (2018) -
Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum
por: Thomas, Margaret L., et al.
Publicado: (2018) -
Genetics and epigenetics of pediatric leukemia in the era of precision medicine
por: Ramos, Kristie N, et al.
Publicado: (2018) -
Human-specific GAPDH qRT-PCR is an accurate and sensitive method of xenograft metastasis quantification
por: Dahn, Margaret L., et al.
Publicado: (2020)